Mymetics Corp (MYMX)

[bow-tie]

23 SEP UPPERTON PHARMA SOLUTIONS INVESTMENT INCREASES TABLETTING CAPABILITIES
Posted at 11:11h in News
https://biocity.co.uk/upperton-investment/

23 SEP UPPERTON PHARMA SOLUTIONS INVESTMENT INCREASES TABLETTING CAPABILITIES
Posted at 11:11h in News Share
Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) has significantly increased its tablet manufacturing capabilities following a strategic investment in a new state-of the-art tablet press. This investment will enhance the company’s development and manufacturing capabilities whilst strengthening their ability to support clients’ research, development and clinical manufacturing needs.
The new cutting edge tablet press, a Futorque X- by KG-Pharma is designed specifically to support both R&D studies and production batches. Indeed the unique features of this machine mean that it equally capable of producing up to 130,000 tablets per hour or supporting DoE and research studies with minimal material and can accommodate multiple tooling formats.